KRTAP12-4 inhibitors are chemical compounds that target and inhibit the activity of keratin-associated protein 12-4 (KRTAP12-4). This protein is a member of the keratin-associated protein (KAP) family, which plays a crucial role in the structural integrity of keratin fibers. Keratin fibers are essential components of hair, nails, and other epithelial structures, and KRTAP12-4 specifically interacts with keratin intermediate filaments to modulate their assembly and stabilization. By inhibiting KRTAP12-4, these inhibitors can alter the behavior of keratin filaments, potentially leading to changes in their structural organization, mechanical properties, or overall function. KRTAP12-4 inhibitors are typically designed to interfere with the binding sites or conformational changes required for KRTAP12-4 to associate with keratin filaments.
The molecular structure of KRTAP12-4 inhibitors often includes elements that allow them to selectively bind to the KRTAP12-4 protein, disrupting its normal interactions with keratin proteins. These compounds may possess a variety of chemical scaffolds, including small organic molecules, peptides, or other biologically derived structures. The specificity of KRTAP12-4 inhibitors is critical, as targeting KRTAP proteins requires precise molecular recognition to avoid affecting other members of the keratin family or associated proteins. Research into KRTAP12-4 inhibitors often focuses on understanding how inhibition of this protein affects the biochemical properties of keratin-based structures and the molecular pathways involved in keratin regulation. Detailed structural studies of KRTAP12-4 and its interactions with inhibitors are essential to uncover how these compounds exert their effects at the molecular level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This cytidine analogue could lead to the hypomethylation of the KRTAP12-4 gene promoter, resulting in the downregulation of its mRNA synthesis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may prevent the deacetylation of histones associated with the KRTAP12-4 gene, thereby repressing the initiation of its transcription. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate could decrease KRTAP12-4 expression by inducing a more condensed chromatin structure around the gene, limiting transcriptional activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid may directly inhibit the expression of KRTAP12-4 by maintaining histones in an acetylated state, which can repress gene transcription. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG 108 could reduce the expression of KRTAP12-4 by blocking the methylation of cytosine residues within its promoter region, leading to transcriptional silencing. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
5-Aza-2′-Deoxycytidine could decrease KRTAP12-4 levels by incorporating into DNA during replication and irreversibly inhibiting DNA methyltransferase, leading to promoter demethylation. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
By binding to the DNA in the control regions of the KRTAP12-4 gene, Mithramycin A could inhibit the binding of transcription factors necessary for its transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid may repress the transcription of KRTAP12-4 by activating retinoic acid receptors that interfere with the promoter activity of the gene. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $107.00 | 3 | |
Spironolactone could indirectly downregulate KRTAP12-4 expression by antagonizing aldosterone, which may alter the hormonal balance controlling hair follicle gene expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Hydroxyurea may reduce KRTAP12-4 expression by disrupting the DNA replication process, which can lead to a nonspecific decrease in gene expression, including that of KRTAP12-4. | ||||||